Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Not generally habit-forming and the desire to use it can decrease with repeated use; however, compulsive redosing is atypically prominent for a psychedelic tryptamine, likely due to its short duration, hedonic effects, and rapid onset/offset profile. May possess higher liability for frequent consumption relative to most psychedelics.
The toxicity and long-term health effects of recreational use have not been studied in any scientific context and the exact toxic dose is unknown. This is a research chemical with very limited history of human usage.
Risk of adverse psychological reactions including psychosis is noted primarily in combination with other substances such as cannabis, lithium, or stimulants; psychosis from the substance alone is not well-documented. As with other psychedelics, risk increases with higher doses.
Described as a likely rare effect that may occur in predisposed individuals, especially under physically taxing conditions such as dehydration, fatigue, or undernourishment. No documented cases of seizures have been reported with this compound alone.
4-AcO-DiPT was first characterized in the scientific literature by Alexander Shulgin, with documentation appearing by 2003. The compound is described in TiHKAL (Tryptamines I Have Known and Loved), Shulgin's comprehensive reference work on tryptamine compounds co-authored with Ann Shulgin.…
Listed as a Schedule B controlled substance under Danish drug control legislation.
Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) as of July 18, 2019. Production, import with intent to distribute, administration to others, and trading are punishable offenses. Possession is illegal but not subject to criminal penalties.
Classified as a health hazard under the Act on the Prohibition of Certain Goods Dangerous to Health (Lagen om förbud mot vissa hälsofarliga varor) as of March 1, 2005, in regulation SFS 2005:26. Both possession and sale are prohibited.
Controlled under the Misuse of Drugs Act 1971. This classification applies because 4-AcO-DiPT is an ester of 4-HO-DiPT, which is controlled under the tryptamine catch-all clause.
Banned in December 2014 under a government regulation that prohibited over 100 psychoactive chemicals.
Controlled under the Pharmaceutical Affairs Law, making both possession and sale illegal.
Specifically named as a controlled substance under Verzeichnis E of Swiss narcotics legislation.
Not scheduled under the Controlled Substances Act. However, due to structural similarities to scheduled tryptamines such as psilocin, possession and sale for human consumption may be prosecuted under the Federal Analogue Act. Pending cases have existed since July 2004 involving vendors selling this substance, though no convictions have established further legal precedent.
12 sources cited